Aurobindo Pharma to sell entire 24.5% share held by Aurogen

Aurogen South Africa (Pty) Ltd., (Aurogen) a wholly owned step-down subsidiary of Aurobindo Pharma Limited in South Africa, has entered into an agreement with Rene Glyne Family trust to sell and dispose of the entire 24.5% shares held by Aurogen. After the disposal of 24.5% shares held by Aurogen, Aurogen ceased to be the joint venture partner of Novagen BBBEE Invest Co (Proprietary) Limited.

USFDA completes PAI of Lupin’s biotech facility in Pune

Lupin Limited has informed that the USFDA has completed a Pre-Approval Inspection (PAI) of its Biotech facility located in Pune, India. The inspection was carried out from September 25, 2024 to October 4, 2024, and concluded with five observations. The company is addressing these observations comprehensively and will respond to the USFDA within the stipulated time frame.